Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

75%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 23 (75.0%)

N/A1 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

Clinical Trials (4)

Showing 4 of 4 trials

NCT00000251Phase 2

Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

Completed

NCT00000252Phase 2

Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

Completed

NCT00000249Phase 2

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

Completed

NCT00000253Not Applicable

Effects of Nitrous Oxide: A Dose-Response Analysis - 5

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4